Llorenç Rovirosa

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Alba Azagra, Ainara Meler, Oriol de Barrios, Laureano Tomás-Daza, Olga Collazo, Beatriz Monterde, Mireia Obiols, Llorenç Rovirosa, Maria Vila-Casadesús, Mónica Cabrera-Pasadas, Mar Gusi-Vives, Thomas Graf, Ignacio Varela, José Luis Sardina, Biola M Javierre, Maribel Parra
The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte development. Nucleic acids research 50 (15) (2022)
Jordi Minguillón, Maria José Ramírez, Llorenç Rovirosa, Pilar Bustamante-Madrid, Cristina Camps-Fajol, Gorka Ruiz de Garibay, Hermela Shimelis, Helena Montanuy, Roser Pujol, Gonzalo Hernandez, Massimo Bogliolo, Pau Castillo, Penny Soucy, Griselda Martrat, Antonio Gómez, Daniel Cuadras, María J García, Javier Gayarre, null Cimba, Conxi Lázaro, Javier Benítez, Fergus J Couch, Miguel Angel Pujana, Jordi Surralles
CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival. Cancers 14 (2) (2022)
Helena Montanuy, Águeda Martínez-Barriocanal, Jose A Casado, Llorenç Rovirosa, Maria José Ramírez, Rocío Nieto, Carlos Carrascoso-Rubio, Pau Riera, Alan González, Enrique Lerma, Adriana Lasa, Jordi Carreras-Puigvert, Thomas Helleday, Juan A Bueren, Diego Arango, Jordi Minguillón, Jordi Surrallés
Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (12) (2020)

Llorenç Rovirosa.css-eqlu8i{font-size:small;padding-left:4px;}